GMP manufactured kits for oncology and other chronic diseases
Services at the cutting edge of proteomic diagnostics
Our CLIA and biomarker services offer a suite of highly sensitive, specific, and selective proteomic tests for diabetes and other metabolic disorders as well as for research use only.
Poised for Growth
Nuclea continues to innovate our proprietary technology and mass spec testing capabilities are fueling growth across five major cancer types as well as metabolic disease. We have a robust pipeline and are expanding our growth in global markets.